JADDP 2015-007 JADA vs J-4077

In November 2015 the Japan Anti-Doping Agency (JADA) has reported an anti-doping rule violation against the Athlete J-4077 (the Athlete) after his sample tested positive for the prohibited substance oxilofrine. After notification a provisional suspension was ordered. The Athlete filed a statement in his defence and he was heard for the Japan Anti-Doping Disciplinary Panel.

The Athlete denied the intentional use of doping and stated that he had purchased on the internet a supplement SP250 and researched the ingredients of the product before using. The Athlete asserted that the supplement manufacturer was formally accredited by the Japan Bodybuilding & Fintness Federation.
The Panel finds that such supplements clearly have a warning label and the Athlete was already informed by his Sports Federation about the risks with supplements purchased on the internet.

Considering the circumstances the Japan Anti-Doping Disciplinary Panel decides on 8 December 2015 to impose a 2 year period of ineligibility on the Athlete starting on the date of the provisional suspension i.e. on 2 November 2015.

Original document

Parameters

Legal Source
National Decisions
Date
8 December 2015
Arbitrator
Murayama, Masahiro
Shishido, Kazuki
Tsukagoshi, Katsumi
Original Source
Japan Anti-Doping Agency (JADA)
Country
Japan
Language
English
ADRV
Adverse Analytical Finding / presence
Legal Terms
Negligence
No intention to enhance performance
Period of ineligibility
Sport/IFs
Bodybuilding & Fitness (IFBB) - International Federation of Bodybuilding & Fitness
Other organisations
Japan Anti-Doping Agency (JADA)
Japan Anti-Doping Disciplinary Panel (JADDP)
Laboratories
Tokyo, Japan: Anti-Doping Laboratory
Doping classes
S6. Stimulants
Substances
Oxilofrine (methylsynephrine)
Various
Contamination
Supplements
Document type
Pdf file
Date generated
26 July 2016
Date of last modification
10 January 2019
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin